2002Acta Academiae Medicinae ZunyiRequires access

The correlation and clinical significance between the expression of c-erbB-2 with lymph node metastasis in breast carcinoma

Zheng Zhou

Open publisher page 0 citations

Abstract

Objective To investigate the relationship between the expression of c erbB 2 and lymph node metastasis in breast carcinoma and the significance of the differential diagnosis between benign and malignant breast deseases. Methods The expression of c erbB 2 was detected by immunohistochemical S P methods in 40 cases of breast carcinoma and 10 cases of benign breast diseases. Results The positive expression rate of c erbB 2 was 67.50% in breast carcinoma and 30.00% in benign breast diseases (P0.05).The positive expression rate of c erbB 2 was 86.30% in 22 cases of breast carcinoma with axilliaris lymph node metastasis and 44.44% in 18 cases of breast carcinoma without metastasis(P0.01).Conclusions Detection of c erbB 2 was of value to the differential diagnosis between benign and malignant breast diseases and in assessing the prognosis of breast carcinoma.[

About this research paper

What this paper is about

Objective To investigate the relationship between the expression of c erbB 2 and lymph node metastasis in breast carcinoma and the significance of the differential diagnosis between benign and malignant breast deseases. Methods The expression of c erbB 2 was detected by immunohistochemical S P methods in 40 cases of breast carcinoma and 10 cases of benign breast diseases. Results The positive expression rate of c erbB 2 was 67.50% in breast carcinoma and 30.00% in benign breast diseases (P0.05).The positive expression rate of c erbB 2 was 86.30% in 22 cases of breast carcinoma with axilliaris lymph node metastasis and 44.44% in 18 cases of breast carcinoma without metastasis(P0.01).Conclusions Detection of c erbB 2 was of value to the differential diagnosis between benign and malignant breast diseases and in assessing the prognosis of breast carcinoma.[

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the relationship between the expression of c erbB 2 and lymph node metastasis in breast carcinoma and the significance of the differential diagnosis between benign and malignant breast deseases. Methods The expression of c erbB 2 was detected by immunohistochemical S P methods in 40 cases of breast carcinoma and 10 cases of benign breast diseases. Results The positive expression rate of c erbB 2 was 67.50% in breast carcinoma and 30.00% in benign breast diseases (P0.05).The positive expression rate of c erbB 2 was 86.30% in 22 cases of breast carcinoma with axilliaris lymph node metastasis and 44.44% in 18 cases of breast carcinoma without metastasis(P0.01).Conclusions Detection of c erbB 2 was of value to the differential diagnosis between benign and malignant breast diseases and in assessing the prognosis of breast carcinoma.[

Key concepts: Breast carcinoma, Medicine, Metastasis, Immunohistochemistry, Carcinoma, Breast cancer, Oncology, Lymph node metastasis

Related papers

Back to paper searchBrowse research topicsOriginal source
The correlation and clinical significance between the expression of c-erbB-2 with lymph node metastasis in breast carcinoma — Research Paper | ScholarLens